However, from a clinical point of view, using IL-36α as a diagnostic biomarker in BS patients with mucocutaneous or ocular involvement is not necessary, as most mucocutaneous manifestations (such as genital ulcers) or ocular ones (such as posterior uveitis) are almost pathognomonic of BS [4]. Here, IL36A is linked to posterior uveitis.